BCL6B has been shown to play a critical role in the initiation and progression of multiple solid tumors, including hepatocellular carcinoma, gastric cancer, colorectal cancer, breast cancer, cervical cancer, and various lymphomas. Here, BCL6B is linked to breast carcinoma.